Autoimmune Hemolytic Anemia (AIHA) is a condition where the immune system mistakenly attacks and destroys red blood cells, leading to anemia. This disorder can be classified into different types ...

Atypical Hemolytic Uremic Syndrome market Forecast. DelveInsight's Atypical Hemolytic Uremic Syndrome Market report offers an in-depth understanding of the ...

Hereditary spherocytosis (HS) is a genetic condition that leads to hemolytic anemia, a disorder where red blood cells are destroyed faster than they can be made. This condition is characterized by ...

This report details a rare and severe case of ceftriaxone-induced hemolytic anemia (CIHA), hemodynamic instability and hemolytic crisis in a 54-year-old woman after intravenous infusion of ceftriaxone ...

Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in protein degradation therapies, has been ...

Inaticabtagene autoleucel is under clinical development by Juventas Cell Therapy and currently in Phase I for Acquired (Autoimmune) Hemolytic Anemia. According to GlobalData, Phase I drugs for ...

Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment ...

In pregnancies at risk of hemolytic disease of the fetus and newborn (HDFN), amniocentesis is used to identify the fetus’s ...

The patient was diagnosed with refractory autoimmune hemolytic anemia (AIHA) and treated with Rituximab which showed marked improvement in AIHA. Therefore, Rituximab can be considered in managing ...

You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your ...

The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD.